NCT00232583View on ClinicalTrials.gov

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Metformin

Metformin 1000mg/BID

DRUG

Insulin

Insulin Novolg 70/30 per protocol titration

DRUG

Metfomin

Metformin 1000mg/BID

DRUG

Pioglitazone

Pioglitazone 45mg

DRUG

glyburide

Glyburide per protocol titration

Trial Locations (1)

75390

University of Texas Southwestern, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT00232583 - Preservation of Beta-cell Function in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter